LymeNet Home LymeNet Home Page LymeNet Flash Discussion LymeNet Support Group Database LymeNet Literature Library LymeNet Legal Resources LymeNet Medical & Scientific Abstract Database LymeNet Newsletter Home Page LymeNet Recommended Books LymeNet Tick Pictures Search The LymeNet Site LymeNet Links LymeNet Frequently Asked Questions About The Lyme Disease Network LymeNet Menu

LymeNet on Facebook

LymeNet on Twitter




The Lyme Disease Network receives a commission from Amazon.com for each purchase originating from this site.

When purchasing from Amazon.com, please
click here first.

Thank you.

LymeNet Flash Discussion
Dedicated to the Bachmann Family

LymeNet needs your help:
LymeNet 2020 fund drive


The Lyme Disease Network is a non-profit organization funded by individual donations.

LymeNet Flash Post New Topic  New Poll  Post A Reply
my profile | directory login | register | search | faq | forum home

  next oldest topic   next newest topic
» LymeNet Flash » Questions and Discussion » Medical Questions » autoimmune responses associated with antibiotic-refractory LA.

 - UBBFriend: Email this page to someone!    
Author Topic: autoimmune responses associated with antibiotic-refractory LA.
Marnie
Frequent Contributor (5K+ posts)
Member # 773

Icon 1 posted      Profile for Marnie     Send New Private Message       Edit/Delete Post   Reply With Quote 
Do you still have infectious Bb or are you now autoimmune due to one particular antigen (a protein in Bb)?

T-Helper 17 Cell Cytokine Responses in Lyme Disease Correlate With Borrelia burgdorferi Antibodies During Early Infection
and With*** Autoantibodies*** Late in the Illness in Patients With Antibiotic-Refractory Lyme Arthritis.

Patients with Lyme disease often develop pronounced TH17 immune responses that may help control early infection.

However, late in the disease, excessive TH17 responses may be disadvantageous by contributing to autoimmune responses associated with antibiotic-refractory LA.

https://www.ncbi.nlm.nih.gov/pubmed/28077518 2017

The bile acid tauroursodeoxycholic acid (TUDCA), an inhibitor of cell stress (Kees- tra-Gounder et al., 2016; Xie et al., 2002), inhibited Th17 cell differentiation and counteracted the effect of hypoglycemia, osmotic stress, and hypoxia.

Not permitted to link on this website. Cut and paste and google the. first sentence to find it.


Th17 Cell-Associated Response to Borrelia Burgdorferi Outer Surface Protein A

https://dc.uwm.edu/etd/700/

OspA is linked to Bb's p66she protein - a stress regulator protein.

I wish I knew the dosage and timing of TUDCA (a bile salt conjugated with taurine) and which supplement company makes the best one.

Posts: 9424 | From Sunshine State | Registered: Mar 2001  |  IP: Logged | Report this post to a Moderator
duncan
LymeNet Contributor
Member # 46242

Icon 1 posted      Profile for duncan     Send New Private Message       Edit/Delete Post   Reply With Quote 
Sorry, Marnie, no longer any such thing as abx-refractory LA if the new Guidelines remain unchallenged and unchanged. At least, that's how I understood it.

Evidently they are trying to rebrand it as post-antibiotic LA.

Posts: 228 | From Unitied States | Registered: Jul 2015  |  IP: Logged | Report this post to a Moderator
Marnie
Frequent Contributor (5K+ posts)
Member # 773

Icon 1 posted      Profile for Marnie     Send New Private Message       Edit/Delete Post   Reply With Quote 
Autoimmune Arthritides, Rheumatoid Arthritis, Psoriatic Arthritis, or Peripheral Spondyloarthropathy, Following Lyme Disease

https://www.ncbi.nlm.nih.gov/pubmed/27636905 2017

Or
https://www.medpagetoday.com/resource-centers/ra-pso-psa-related-disorders/systemic-autoimmune-joint-disease-may-follow-lyme-disease/1296

My sis is one dx'd with "autoimmune" post lyme. Oddly, her blood type is A.

Posts: 9424 | From Sunshine State | Registered: Mar 2001  |  IP: Logged | Report this post to a Moderator
Marnie
Frequent Contributor (5K+ posts)
Member # 773

Icon 1 posted      Profile for Marnie     Send New Private Message       Edit/Delete Post   Reply With Quote 
Pub med march 2019:


Biologic Markers of Antibiotic-Refractory Lyme Arthritis in Human: A Systematic Review.


CONCLUSION:
The evidence base of biologic markers for A-RLA is limited. However, a range of promising biomarkers have been identified.

Cytokines and chemokines related to Th17 pathway

together with a number of miRNAs species (miR-146a, miR-155 and let-7a) may be promising candidates in the prediction of A-RLA.

A panel of multiple biomarkers may yield clinically relevant prediction of the possible resistance at the time of LA first diagnosis.

https://www.ncbi.nlm.nih.gov/pubmed/30506261 MARCH 2019

Posts: 9424 | From Sunshine State | Registered: Mar 2001  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code� is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | LymeNet home page | Privacy Statement

Powered by UBB.classic™ 6.7.3


The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:

The Lyme Disease Network of New Jersey
907 Pebble Creek Court, Pennington, NJ 08534 USA


| Flash Discussion | Support Groups | On-Line Library
Legal Resources | Medical Abstracts | Newsletter | Books
Pictures | Site Search | Links | Help/Questions
About LymeNet | Contact Us

© 1993-2020 The Lyme Disease Network of New Jersey, Inc.
All Rights Reserved.
Use of the LymeNet Site is subject to Terms and Conditions.